Page 283 - Tata_Chemicals_yearly-reports-2020-2021
P. 283

Integrated Report   Statutory Reports  Financial Statements
              1-59                60-146             Consolidated


            The details of fund and plan assets position are given below:                               ` in crore
                                                                      TCL                     RALLIS
             Provident Fund                                        As at        As at        As at        As at
                                                           March 31, 2021 March 31, 2020 March 31, 2021 March 31, 2020
             Plan assets at the end of the year                   328.00       326.37       104.07        91.99
             Less: Present value of funded obligation             330.35       340.08       102.15        89.26
             Amount recognised in the Consolidated Balance Sheet   (2.35)      (13.71)           -            -

            Assumptions used in determining present value of obligation of interest rate guarantee under a deterministic approach:
                                                                                             As at        As at
                                                                                     March 31, 2021 March 31, 2020
             Guaranteed rate of return                                                      8.50%        8.50%
             Discount rate for remaining term to maturity of investments               6.41% - 6.45%  6.35% - 6.83%
             Discount rate                                                                  6.50%        6.05%
             Expected rate of return on investments                                    6.41% - 8.57%  7.69% - 7.86%

            41.  Segment information
            41.1 Continuing operations
                (a)  Information about operating segments
                      The Company has 2 reportable segments which are the Company's strategic business units. These business units offer different
                    products and are managed separately. Reportable Segments approved by Board of Directors are as under:
                    -   Basic chemistry products : Soda Ash, Salt and other bulk chemicals
                    -   Specialty products : Nutrition solutions, agri Solutions and advance materials
                                                                                                        ` in crore
                                                                                        Year ended   Year ended
                                                                                     March 31, 2021 March 31, 2020
                 1.   Segment revenue (Revenue from operations)
                    (i)   Basic chemistry products                                         7,608.92     8,013.74
                    (ii)   Speciality products                                             2,580.00     2,328.85
                                                                                          10,188.92    10,342.59
                    Inter segment revenue                                                   (11.54)      (10.06)
                                                                                          10,177.38    10,332.53
                    Unallocated                                                              22.42        24.22
                                                                                          10,199.80    10,356.75
                 2.  Segment result (Reconciliation with profit from continuing operations)
                    (i)   Basic chemistry products                                          728.50      1,355.51
                    (ii)   Speciality products                                              209.33       166.90
                    Total segment results                                                   937.83      1,522.41
                    Net unallocated income/(expenditure)                                     37.91        71.41
                    Finance costs                                                           (367.37)     (341.91)
                    Profit before share of profit/loss from investment in joint ventures and tax     608.37    1,251.91
                    Share of profit\(loss) of joint ventures (net of tax)                    25.62        (3.85)
                    Tax expense                                                             (197.77)     (219.65)
                    Profit for the year from continuing operations                          436.22      1,028.41








                                                                                                           281
   278   279   280   281   282   283   284   285   286   287   288